ash23: corey cutler, md, mph, on gvhd and stem cell transplant | dana-farber cancer institute
Published 8 months ago • 77 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
1:39
dana-farber cancer institute: corey cutler, md ash 2020
-
1:34
what is graft versus host disease? | dana-farber cancer institute
-
2:58
corey cutler, ash 2019: evolving treatment for patients with gvhd
-
1:26
updates in transplantation at ash 2020
-
2:18
stem cell transplant: advances in graft v. host disease
-
1:11
ash23: katie maurer, md, phd, on immune system features and car-t | dana-farber cancer institute
-
1:50
translational and clinical advances in acute gvhd
-
1:19
dana-farber cancer institute: jennifer crombie, md ash 2020
-
0:38
skylark trial update: isa-krd in newly diagnosed, transplant-eligible multiple myeloma
-
2:32
final results of cartitude-1: cilta-cel in heavily pretreated patients with r/r multiple myeloma
-
3:32
research updates in wm from ash 2023
-
3:34
precision oncology update from esmo 2023
-
1:52
asco 2024 - high-dose chemotherapy for recurrent germ cell tumors: hedyeh ebrahimi, md
-
13:49
live from ash 2023: dr brown discusses updated results of the alpine trial in cll
-
1:24
phase i study of cd123 nk cell engager sar443579 in r/r aml, b-all or hr-mds
-
0:56
dr. jaime h. kim: types of ablations
-
1:13
the allg cml13 ascend-cml study: high major molecular responses with asciminib treatment for cp-cml
-
4:08
dr. jeffrey lancet and dr. kenrda sweet at ash 2022